Shunliang Y. Gao

No. 79 Qingchun Road
Hangzhou, 310003, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Integrated Multi-Omics Analysis of Coagulation Dysregulation and Immune Pathway Alterations in 10-Gene Pig-to-Monkey Liver Xenotransplantation: A Case Report.

Integrated Multi-Omics Analysis of Coagulation Dysregulation and Immune Pathway Alterations in 10-Gene Pig-to-Monkey Liver Xenotransplantation: A Case Report.

Journal: Xenotransplantation

Published: January 13, 2026

Robotic vs. open liver resection after neoadjuvant therapy for hepatocellular carcinoma: a propensity score-matched analysis of short- and long-term outcomes.

Robotic vs. open liver resection after neoadjuvant therapy for hepatocellular carcinoma: a propensity score-matched analysis of short- and long-term outcomes.

Journal: Surgical endoscopy

Published: November 27, 2025

Survival Benefit of Combined Systemic and Locoregional Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score-Matched Analysis.

Survival Benefit of Combined Systemic and Locoregional Therapy in Hepatocellular Carcinoma with Portal Vein Tumor Thrombus: A Propensity Score-Matched Analysis.

Journal: Liver cancer

Published: October 30, 2025

Endovascular Intervention of Portal Vein Stenosis in Pediatric Patients After Liver Transplantation: A Single-Center Experience.

Endovascular Intervention of Portal Vein Stenosis in Pediatric Patients After Liver Transplantation: A Single-Center Experience.

Journal: Annals of transplantation

Published: August 19, 2025

Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial.

Neoadjuvant nab-paclitaxel plus gemcitabine followed by modified FOLFIRINOX for resectable pancreatic cancer: A randomized phase 3 trial.

Journal: Cancer cell

Published: May 21, 2025

5-Year survival rate over 20 % in pancreatic ductal adenocarcinoma: A retrospective study from a Chinese high-volume center.

5-Year survival rate over 20 % in pancreatic ductal adenocarcinoma: A retrospective study from a Chinese high-volume center.

Journal: Cancer letters

Published: February 28, 2025

Risk Factors, Manifestations, and Implications of Chyle Leak following Pancreatic Surgery: The Volume May Outweigh the Milky Appearance of the Drainage in a Chyle Leak.

Risk Factors, Manifestations, and Implications of Chyle Leak following Pancreatic Surgery: The Volume May Outweigh the Milky Appearance of the Drainage in a Chyle Leak.

Journal: Annals of surgery

Published: December 11, 2024

Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial.

Adjuvant transarterial chemoembolization for hepatocellular carcinoma following curative resection: A randomized, open-label, phase 3 trial.

Journal: Hepatology (Baltimore, Md.)

Published: October 06, 2024

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study.

Transarterial Chemoembolization With or Without Systemic Therapy for Unresectable Hepatocellular Carcinoma: A Retrospective Comparative Study.

Journal: Cancer medicine

Published: May 09, 2024

Optimizing the Management Strategies of Delayed Postpancreaticoduodenectomy Hemorrhage: Lessons From 2013 Consecutive Pancreaticoduodenectomies.

Optimizing the Management Strategies of Delayed Postpancreaticoduodenectomy Hemorrhage: Lessons From 2013 Consecutive Pancreaticoduodenectomies.

Journal: Annals of surgery

Published: April 22, 2024

Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study.

Envafolimab plus lenvatinib and transcatheter arterial chemoembolization for unresectable hepatocellular carcinoma: a prospective, single-arm, phase II study.

Journal: Signal transduction and targeted therapy

Published: April 09, 2024

Risk factors for post-operative portal vein stenosis in pediatric liver transplantation: a single center case-control study.

Risk factors for post-operative portal vein stenosis in pediatric liver transplantation: a single center case-control study.

Journal: Pediatric surgery international

Published: April 05, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026